![Kevin Trapp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Trapp
Corporate Officer/Principal bei
DBV TECHNOLOGIES
Profil
Kevin Trapp is currently Chief Commercial Officer at DBV Technologies SA since 2025.
Formerly, Mr. Trapp was Senior Vice President-Portfolio & Access Strategy at Bristol Myers Squibb Co. from 2014 to 2016 and Chief Commercial Officer at DBV Technologies SA from 2018 to 2020.
Mr. Trapp completed undergraduate education at the University of Connecticut School of Business.
Aktive Positionen von Kevin Trapp
| Unternehmen | Position | Beginn |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 03.11.2025 |
Ehemalige bekannte Positionen von Kevin Trapp
| Unternehmen | Position | Ende |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 02.10.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.06.2016 |
Ausbildung von Kevin Trapp
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
University of Connecticut School of Business
 University of Connecticut School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
